Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]PARPi PET/CT Imaging in Head and Neck Cancer
NCT03631017Phase 2Active, not recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Aug 2018
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of [18F]PARPi in head and neck cancer (HNC), sponsored by Memorial Sloan Kettering Cancer Center. Started Aug 2018; status: active, not recruiting.
02
Drugs
[18F]PARPi
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT03631017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03631017.